EphB–ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells-Reference-Cited by-同舟云学术

EphB–ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells

Published:2007-09-30 Issue:11 Volume:39 Page:1376-1383
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Cortina Carme,Palomo-Ponce Sergio,Iglesias Mar,Fernández-Masip Juan Luis,Vivancos Ana,Whissell Gavin,Humà Mireia,Peiró Nerea,Gallego Lourdes,Jonkheer Suzanne,Davy Alice,Lloreta Josep,Sancho Elena,Batlle Eduard

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.2007.11.pdf

Reference21 articles.

1. Batlle, E. et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrin-B. Cell 111, 251–263 (2002).

2. van de Wetering, M. et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241–250 (2002).

3. Batlle, E. et al. EphB receptor activity suppresses colorectal cancer progression. Nature 435, 1126–1130 (2005).

4. Clevers, H. & Batlle, E. EphB/Ephrin-B receptors and Wnt signaling in colorectal cancer. Cancer Res. 66, 2–5 (2006).

5. Huusko, P. et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat. Genet. 36, 979–983 (2004).

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinoma;Pharmacological Research;2024-09

2. EPHA1 and EPHB4 tyrosine kinase receptors regulate epithelial morphogenesis;2024-07-16

3. Ephs in cancer progression: complexity and context-dependent nature in signaling, angiogenesis and immunity;Cell Communication and Signaling;2024-05-29

4. Potential role of the Eph/ephrin system in colorectal cancer: emerging druggable molecular targets;Frontiers in Oncology;2024-04-02

5. EphB3 protein is a potential ancillary diagnostic biomarker for thyroid cancers;Annals of Diagnostic Pathology;2024-04